זג'ולה 100 מג
medison pharma ltd - niraparib as tosylate monohydrate - קפסולה קשיחה - niraparib as tosylate monohydrate 100 mg - niraparib
hearing aids and accessories for hearing aids bernafon switzerland
מדנט בע"מ - כלל האוכלוסיה - שמיעה
קנידריל 100 מג טבליות לכלבים וטרינרי
a.l. medi-market ltd. - carprofen - טבליה - carprofen 100 mg
קנידריל 20 מג טבליות לכלבים וטרינרי
a.l. medi-market ltd. - carprofen - טבליה - carprofen 20 mg
קנידריל 50 מג טבליות לכלבים וטרינרי
a.l. medi-market ltd. - carprofen - טבליה - carprofen 50 mg
אקסמסטאן אקטביס 25 מג
devries & co. ltd - exemestane - טבליות מצופות פילם - exemestane 25 mg - exemestane
זג'ולה 100 מג
medison pharma ltd - niraparib as tosylate monohydrate - קפסולה קשיחה - niraparib as tosylate monohydrate 100 mg - niraparib
ונופר
cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.
ונופר
cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.
אפרקס 1000
j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat